Live Salesforce, Inc. Vote →

Never Miss Important Company Updates Again

Get AI-powered summaries of SEC filings delivered to your inbox

Follow your favorite stocks and get email alerts when they release important updates. Completely free.

Covers 5,000+ public companies
Get started →
Sign up to stay up to date with the stocks you care about
Follow Sunshine Biopharma, Inc

Get SEC filing alerts via email and in your feed for Sunshine Biopharma, Inc

SBFM SBFMW

Sunshine Biopharma, Inc

About Sunshine Biopharma, Inc

Sunshine Biopharma Inc. is a pharmaceutical company focused on developing and commercializing generic, OTC, and proprietary medicines across therapeutic areas such as oncology and antivirals. It owns a portfolio of approved generics in Canada, develops novel drug candidates including mRNA-based cancer therapies and coronavirus inhibitors, and seeks to expand its market presence through licensing, licensing agreements, and strategic partnerships. The company emphasizes innovation, regulatory compliance, and competitive positioning in global markets.
This description was generated via AI from an annual report. Updated 8 months ago.

Latest SEC Filings from Sunshine Biopharma, Inc

1
1
Sunshine Biopharma, Inc Sunshine Biopharma Reports Q1 2026 Revenue of $8.1 Million, Net Loss of $1.2 Million

Via official filing (AI summary) | 22 days ago | 0 comments

2
1
Sunshine Biopharma, Inc Sunshine Biopharma Reports 4% Revenue Growth to $36.3 Million, Faces Increased Net Loss

Via official filing (AI summary) | 2 months ago | 0 comments

3
1
Sunshine Biopharma, Inc Sunshine Biopharma Reports 11.6% Revenue Growth in Q3 2025, Net Loss Improves

Via official filing (AI summary) | 7 months ago | 0 comments

4
1
Sunshine Biopharma, Inc Sunshine Biopharma Reports Q2 2025 Revenue Increase to $9.41 Million, Net Loss Grows

Via official filing (AI summary) | 10 months ago | 0 comments

5
1
Sunshine Biopharma, Inc Sunshine Biopharma Reports 18% Revenue Growth to $8.9 Million in Q1 2025

Via official filing (AI summary) | about 1 year ago | 0 comments

6
1
Sunshine Biopharma, Inc Sunshine Biopharma Reports Revenue Growth to $34.9 Million, Faces Net Loss of $5.1 Million

Via official filing (AI summary) | about 1 year ago | 0 comments

7
1
Sunshine Biopharma, Inc Sunshine Biopharma Reports 42% Revenue Growth, Net Loss in Q3 2024

Via official filing (AI summary) | over 1 year ago | 0 comments